Epidemiological evidence shows exercise and smoking as modifiable risk factors reducing Parkinson’s disease risk, suggesting shared neuroprotective mechanisms.
Compelling epidemiological evidence suggests that exercise and smoking are modifiable risk factors that are linked to a reduced risk of Parkinson’s disease, possibly because they both exert protective effects on neurodegeneration. Like Yin and Yang, these two risk factors represent opposite ends of a spectrum: exercise is universally embraced, while smoking is rightly eschewed. Yet, intriguingly, preclinical evidence suggests that at their biological cores, exercise and smoking may share strikingly similar working mechanisms in favorably modifying the disease course. Here, we deconstruct these overlapping and putative neuroprotective mechanisms. Our aim is to transform this unexpected overlap into an actionable perspective towards identifying novel targets for disease-modifying therapies that can slow the progression of Parkinson’s disease. We stress that while both factors may theoretically inform disease-modifying strategies for PD, in practice, only exercise should be promoted for its health benefits, whereas smoking is firmly contraindicated due to its known detrimental health effects.
No takes yet. Share an insight, caveat, or question.
Daalen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: